Researcher from Houston Methodist Hospital Discusses Findings in Herpes Zoster Virus (Development of Shingles on Tofacitinib Despite Completion of Recombinant Varicella-Zoster Virus Vaccine Series).

MLA

“Researcher from Houston Methodist Hospital Discusses Findings in Herpes Zoster Virus (Development of Shingles on Tofacitinib Despite Completion of Recombinant Varicella-Zoster Virus Vaccine Series).” Vaccine Weekly, Jan. 2024, p. 649. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edo&AN=174508390&authtype=sso&custid=ns315887.

APA

Researcher from Houston Methodist Hospital Discusses Findings in Herpes Zoster Virus (Development of Shingles on Tofacitinib Despite Completion of Recombinant Varicella-Zoster Virus Vaccine Series). (2024). Vaccine Weekly, 649.

Chicago

“Researcher from Houston Methodist Hospital Discusses Findings in Herpes Zoster Virus (Development of Shingles on Tofacitinib Despite Completion of Recombinant Varicella-Zoster Virus Vaccine Series).” 2024. Vaccine Weekly, January, 649. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edo&AN=174508390&authtype=sso&custid=ns315887.